These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 28438902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
    Yamakawa T, Tanaka S, Numaguchi K, Yamakawa Y, Motley ED, Ichihara S, Inagami T.
    Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway.
    Wang S, Chen C, Su K, Zha D, Liang W, Hillebrands JL, Goor Hv, Ding G.
    Ren Fail; 2016 Jan; 38(2):268-75. PubMed ID: 26652313
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.
    Guo WG, Su FF, Yuan LJ, Yang GD, Shi XQ, Li RY, Shu Q, Liu XT, Lu ZF, Zheng QS.
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):40-5. PubMed ID: 19515066
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.
    Liu X, Li T, Sun S, Xu F, Wang Y.
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H279-85. PubMed ID: 16100249
    [Abstract] [Full Text] [Related]

  • 19. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L, Meng W, Ding J, Cheng M.
    Biochem Biophys Res Commun; 2016 Apr 29; 473(2):455-61. PubMed ID: 26970306
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy.
    Chang L, Yang R, Wang M, Liu J, Wang Y, Zhang H, Li Y.
    Am J Med Sci; 2012 Mar 29; 343(3):220-6. PubMed ID: 21841463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.